TERT and hepatocellular carcinoma: In dysplastic nodules and established HCC, mutations of TERT promoter, which encodes the synthesis of telomere reverse transcriptase, are frequent (6% in LGDNs, 20% in HGDNs, and 60% in HCC) [15].